Practical management of liver transplant recipients for hepatitis C

S. Saab, R. W Busuttil

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


Hepatitis C is one of the leading indications for liver transplantation. Recipients can expect at least a short-term survival equivalent to other indications for liver transplantation. However, the rates of cirrhosis and decompensation development is substantially faster than those rates seen in non-transplant setting. Advances in antiviral therapy are now associated with a sustained virological response of 20% with combination antiviral with interferon and ribavirin. Higher response rates are expected with utilizing pegylated interferon.

Original languageEnglish (US)
Pages (from-to)479-489
Number of pages11
JournalMinerva Chirurgica
Issue number4
StatePublished - Aug 2003


  • Antiviral agents
  • Hepatitis C
  • Liver cirrhosis
  • Liver transplantation

ASJC Scopus subject areas

  • Surgery


Dive into the research topics of 'Practical management of liver transplant recipients for hepatitis C'. Together they form a unique fingerprint.

Cite this